NA89
NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED
01/09/2026
Back to search
Official data from USPTO
EMAXHEALTH
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: CombinedOffice: United States
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
40
Latest update
02/03/2026
Trademark type
Combined
Nice classes
35, 36, 44
Filing date
07/14/2014
Registration date
09/22/2015
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
01/09/2026
Last transaction
02/03/2026
Responsible office
United States Patent and Trademark Office
Status code
800
Official register
Principal Register
First use anywhere
07/20/2010
First use in commerce
07/20/2010
Drawing code
3
Owner type
16
Owner location
DELRAY BEACH, FL
Examiner
COGAN, BRITTNEY LORRAINE
Current location
PUBLICATION AND ISSUE SECTION
Mark description
The mark consists of a blue circle with a yellow lattice superimposed on the circle, representative of a globe design, and a yellow and green horizontal arrow appearing across the blue circle pointed to the right; a faint mirrored image of the aforementioned globe design appears below the design, appearing as a reflection; the words "EMAXHEALTH" appear beneath the design with the letter "E" and the word "HEALTH" in yellow stylized font, with the term "MAX" appearing in blue stylized lettering; the color white represents transparent areas and is not part of the mark.
Holders and representatives
Holders
EMAX HEALTH SYSTEMS, LLC
EMAX HEALTH SYSTEMS, LLC
Representatives
John Zaccaria Notaro, Michalos & Zaccaria P.C.
Technical classification
Nice Classes
Class 35Class 36Class 44
Vienna Codes
No Vienna codes available.
Goods and services
Class 35
Pharmaceutical cost management services and drug utilization review services; health care utilization and review services; specialized pharmacy services for patients with particular medical conditions; health care cost review; health care cost containment; collection and compilation of information into computer databases in the fields of healthcarepharmaceuticalsspecialty pharmacy; market research; providing reimbursement informationdrug pricingpayment trackingco-payment data and other market intelligence to health care providersinsurers and consumers; managed care servicesutilization review and pre-certification services; electronic processing of health care information; business development services; promoting and marketing the brands of others; Business information servicescollectionreporting and analysis of healthcare dataretail and specialty pharmacy dataclinical trialsmedical datainsurance claimshospital datapharmaceuticalsdosagefrequencyclinical effectiveness and patient response to therapyscientific research in compiling data to determine the efficacy of biopharmaceutical products on a subset patient population for business purposes and for assisting decision making with respect to contracting with health insurance providers and pharmacy benefit managers to improve market accessformulary statusbrand preferencingeconomic evaluation of rebate or discounting programs
Class 36
Providing counseling and consulting in the field of healthcare benefits; providing information about healthcare insurance plans; providing a database featuring information and statistics about patient reimbursement and insurance coverage for pharmaceuticals and medical devices; providing financial advice to patients; claims administration in the field of health insurance; insurance servicesbenefits verification; debit card services; Healthcare research servicesproviding information regarding health care insurance and payment options to health care providersinsurersconsumers; Consulting servicesproviding information about health care plans and medication optionsproducts and programsbenefit plans
Class 44
Pharmaceutical advice; health care servicesproviding a database of diseases and the collection of disease data and information all for treatment and diagnostic purposes; medical evaluation servicesfunctional assessment program for patients receiving medical rehabilitation services for purposes of guiding treatment and assessing program effectiveness; Healthcare research servicesproviding information regarding health care treatment and specialty pharmaceuticals to health care providersinsurersconsumers
Publications
History of USPTO decisions and trademark events.
40 publications found
RNL1
REGISTERED AND RENEWED (FIRST RENEWAL - 10 YRS)
01/09/2026
89AG
REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED
01/09/2026
APRE
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
12/30/2025
E89R
TEAS SECTION 8 & 9 RECEIVED
09/22/2025
ASGN
AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
01/22/2025
REM2
COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED
09/22/2024
NAS8
NOTICE OF ACCEPTANCE OF SEC. 8 - E-MAILED
12/21/2021
8.OK
REGISTERED - SEC. 8 (6-YR) ACCEPTED
12/21/2021
APRE
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
12/21/2021
ES8R
TEAS SECTION 8 RECEIVED
07/23/2021
REM1
COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
09/22/2020
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
01/24/2020
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
01/24/2020
CHAN
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
04/11/2019
COAR
TEAS CHANGE OF OWNER ADDRESS RECEIVED
04/11/2019
R.PR
REGISTERED-PRINCIPAL REGISTER
09/22/2015
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
07/07/2015
PUBO
PUBLISHED FOR OPPOSITION
07/07/2015
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
06/17/2015
PBCR
WITHDRAWN FROM PUB - OG REVIEW QUERY
04/07/2015
PREV
LAW OFFICE PUBLICATION REVIEW COMPLETED
03/23/2015
ALIE
ASSIGNED TO LIE
03/23/2015
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
03/03/2015
XAEC
EXAMINER'S AMENDMENT ENTERED
03/03/2015
GNEN
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
03/03/2015
GNEA
EXAMINERS AMENDMENT E-MAILED
03/03/2015
CNEA
EXAMINERS AMENDMENT -WRITTEN
03/03/2015
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
02/09/2015
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
02/09/2015
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
02/09/2015
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
10/30/2014
GNRT
NON-FINAL ACTION E-MAILED
10/30/2014
CNRT
NON-FINAL ACTION WRITTEN
10/30/2014
DOCK
ASSIGNED TO EXAMINER
10/24/2014
CHAN
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
08/19/2014
COAR
TEAS CHANGE OF OWNER ADDRESS RECEIVED
08/19/2014
MDSM
NOTICE OF DESIGN SEARCH CODE E-MAILED
07/18/2014
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
07/17/2014
NWAP
NEW APPLICATION ENTERED
07/17/2014
Continuous trademark protection
Get notified about every new filing that threatens EMAXHEALTH or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.